Heads Up -- New Vertex Data from AASLD

Abstracts to be published sometimes today for Treatment-Naive and Treatment-Failure Genotype 1 HCV Patients, and Clinical Data Exploring Twice-Daily Dosing Regimens

http://biz.yahoo.com/bw/080924/20080924005206.html?.v=1

[Andiamo1]

I am one of the first people in the treatment failure 48 week arm, so that data should start to surface soon.  I am curious to see if the 24 + 24 week arm had a statistically significant improvement over the 24 week arm.  I hope for future patients sake, it didn't!  

Vertex stock took a good jump today, so I guess people have high hopes.

[Andiamo1]

I should have been  more consistent and used 12+ 12 instead of 24 week arm.

[willows]

Well, it is hard for me to sort out exactly what the abstract is saying, but the correction posted was amazing in it's numbers.  Gives a non responder like me, waiting to re tx, a kind of a shiver....a really cool, feels so good shiver, like maybe it's okay to hope for something better finally.    Helps me to put the thought of going back on SOC in a better perspective...if such a thing is possible.  Better days ahead I'm hoping!

Willow

[Andiamo1]

Good luck to you.  I hope the new data gets early approval for Vertex.

I am basking in my SVR and wishing that you get there soon.  Meanwhile as a consolation, the stock is up 16% today on the new results.

Eric